Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. IRT
7. QCOM
8. ASO
9. LAES
10. NTHI

Go back to Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
(NASDAQ: LTRN) Delayed: 1.78 -0.06 (3.26%)
Previous Close $1.84    52 Week High $ 
Open $1.82    52 Week Low $ 
Day High $1.86    P/E N/A 
Day Low $1.76    EPS $ 
Volume 168,769